GIT, Hepatobiliary, Pancreatic Flashcards

1
Q

Zones in the liver & implications?

A

Zone 1: periportal - most prone to toxic injury. Site mainly affected by SECONDARY causes of Cu accumulation.
Zone 2:
Zone 3: centrilobular - most prone to hypoxic injury. Site mainly affected with PRIMARY defects in Cu accumulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breeds predisposed to copper storage hepatopathy?

A

Pure + mixed breeds.
Bedlington terriers, Labs, WHWT, Dobermans, Skye terrier, Dalmatians.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Copper storage hepatopathy in Bedlington terriers - gene mutation, clinical characteristics?

A

Autosomal recessive disorder.
Deletion of exon 2 of copper metabolism domain containing 1 (COMMD1) gene –> complete absence of protein that normally regulates copper metabolism & homeostasis –> affects biliary copper excretion pathway –> copper accumulation in hepatocellular lysosomes.
Acute form - 2-6yo, hepatomegaly, jaundice, hemolytic anemia. Elevated ALT.
Chronic form - middle-aged and older dogs. Less severe CSx, progressive liver damage.
Dx - liver bx. BUT liver [Cu] does not always correlate with the extent of liver damage & dz progression, also may not ID substantial Cu accumulation in hepatocytes in early dz.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Copper metabolism pathway and transporter genes involved?

A

Copper homeostasis relies on regulation of uptake of copper in
the small intestine, cellular metabolism executed by a variety of copper transporters and chaperones, as well as excretion of excessive copper via the biliary tract.

The P-type copper-transporting ATPases, ATP7A and ATP7B are crucial for the regulation of copper homeostasis.
- ATP7A mainly resides at the basal membrane of enterocytes and facilitates copper transport into the portal circulation.
- ATP7B is located at the Golgi complex in hepatocytes and moves to the endo-lysosomal cellular compartments upon copper overload. ATP7B has a dual function. In terms of its biosynthetic role, ATP7B facilitates incorporation of copper into apo-ceruloplasmin within the trans-Golgi network to form ceruloplasmin. Furthermore, ATP7B facilitates excretion of copper into the bile via the apical membrane of hepatocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cu associated hepatitis in Labs - causative gene mutation?

A

Mutations in ATP7A & ATP7B genes leading to amino acid substitutions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WSAVA classification of feline inflammatory liver diseases?

A

3 histopath groups:
1) Neutrophilic (acute & chronic)
2) Lymphocytic
3) Chronic cholangitis 2’ to liver flukes (Platynosomum spp. and Amphimerus pseudofelineus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Liver fluke cholangitis in cats - pathogenesis?

A

Endemic - ‘lizard poisoning’ - eating
infected lizards found in the tropics and subtropics. Fluke resides in the GB & biliary ducts of infected cats, creating inflammation within bile ducts & portal areas.
High burden –> chronic mucoid D+ & icterus. Non-specific signs when chronic (adult flukes persist).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hepatocutaneous syndrome - signalment, skin lesion appearance & locations?

A

Signalment: small-med sized dogs, males > females, median onset 10yo. Breeds reported - Shetland, Cockers, WHWT.

Skin: crusting, ulcerative, painful dermatosis
that affects the mucocutaneous junctions, pressure
points, and footpads with classic histologic features of superficial necrolytic dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the CCECAI and CIBDAI systems stand for (differences) and what is their clinical utility?

A

Both systems used for scoring dogs with IBD. CIBDAI has also been utilised to assess dogs with acute pancreatitis.

CIBDAI = canine IBD activity index.
= 6 components, attitude/activity, appetite, vomiting, stool consistency, stool frequency, weight loss (see table)

CCECAI = canine chronic enteropathy clinical activity index.
= CIBDAI components + serum [albumin], peripheral oedema & ascites, severity of pruritus.
allows better assessment of therapeutic success

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the technique of contrast-enhanced ultrasound & its indications.

A

Salavati JVIM 2020
CEUS uses gas-filled microbubbles (usually sulfur hexafluoride) as a tracer to assess tissue perfusion. The microbubbles remain entirely within the intravascular space & have rheology (flow & deformation) similar to RBCS. Excess sulfur hexafluoride is exhaled, and the phospholipid microbubble shell enters the endogenous phospholipid metabolic pathway. The microbubbles have an elimination half-life of ~6mins; >80% of the administered gas is exhaled via the lungs after 11 mins.

Indications:
Humans - assess mucosal healing with IBD
Dogs - evaluate perfusion abnormalities in several organs (focal splenic lesions, adrenal tumors, prostatic disease); assessment of GIT in healthy dogs & cats, assess duodenal perfusion in dogs with CIE & intestinal LSA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a) DGGR lipase vs traditional lipase assay components?

b) Agreement of DGGR lipase with current gold standard tests for diagnosis of pancreatitis?

A

a) DGGR lipase assay = 1,2-O-dilauryl-rac-glycero glutaric acid-(60-methylresorufin) ester (DGGR) substrate. Traditional lipase = 1,2-diglyceride (1,2 DiG) substrate.

b) High level of agreement between DGGR & spec CPL, similar sensitivity. DGGR is cheaper with more rapid turnaround time, used as screening biomarker in routine biochemistry panels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normal hepatic [copper] in dogs?

A

150-400 μg/g dry weight (parts per million/ppm).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cut-off hepatic Cu level for differentiating primary vs secondary copper hepatopathy?

A

<800ppm likely secondary
>800ppm likely primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the current best indicator of cobalamin (Cbl) status in cats & dogs?
What is the role of this indicator in B12 metabolism?

A

Measurement of methylmalonic acid (MMA) concentrations - indicator of Cbl cellular stores.

Adenosyl-Cbl = cofactor for a) conversion of methylmalonyl-CoA to succinyl-CoA via methylmalonyl-CoA mutase, and b) re-methylation of homocysteine via methionine synthase.

B12 deficiency –> decreased methylmalonyl-CoA mutase activity –> increased serum [MMA].
NB: cats don’t have increased [homocysteine].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Roles of bile acids?

A
  • Aid in digestion & absorption of lipids in the GIT
  • Signalling molecules
  • Primary BA converted to secondary BA by bacteria with 7α-dehydroxylation capabilities.
  • Secondary BAs inhibit growth & germination of C. difficile (in people, possibly in dogs).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1) Which bacteria is involved in bile acid metabolism?
2) Significance in dogs/cats with CE?
3) Diagnostic test available?

A

1) Clostridium hiranonis
Main BA converting bacteria spp in dogs - convert primary BAs to secondary BAs by 7a-dehydroxylation
2) Depleted in CE (also by abx use) –> decreased proportion of secondary BA in colon in these dogs. Can be partially restored with FMT.
3) Included as 1 of 7 bacteria spp. quantified with the faecal dysbiosis index (DI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List primary & secondary bile acids, and their roles.

A

Primary BA:
- Cholic acid, chenodeoxycholic acid
- In the duodenum: solubilise dietary lipids to aid digestion post-prandium

Secondary BA:
- Deoxycholic acid, lithocholic acid
- Bind to transmembrane G protein-coupled bile acid receptor GPBAR-1 (AKA TGR5 as signaling molecules)
- Anti-inflammatory properties.
- Lower glucose concentrations by binding to the farnesoid X receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Differences in bile acid conjugation between cats & dogs?

A
  • Cats: BA exclusively conjugated with taurine (essential AA) - so prone to rapidly developing taurine deficiency with hepatic disease
  • Dogs: taurine or glycine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk factors for PPDH in dogs & cats?

A

Dogs - Weimaraners
Cats - DMH, DLH (Himalayans, Persians)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ductal plate malformations:
1. Define
2. Phenotypes
3. Complications/consequences

A
  1. DPMs = embryonic abnormalities secondary to dysfunction of the primary cilia that result in defective tubulogenesis & affect the formation of bile ducts. (Primary cilia are present in the liver on only
    cholangiocytes, not hepatocytes).
  2. Caroli DPM (malformative medium-to-large bile ducts with irregularly distended or variably sacculated silhouettes, evaginating diverticular buds, and occasional scattered circumferential satellite bile duct profiles, similar to the embryologic ductal plate) or proliferative-like DPM. 1st r/o mechanical cholestasis before diagnosis.
    Expansive cystadenoma DPM - cats > dogs
  3. Pre-sinusoidal hypertension develops due to non-compliant portal fibrosis. Congenital hepatic fibrosis –> variable clinical progression but can lead to acquired PSS & ascites.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which immunohistochemical stains are used to diagnosed copper storage hepatopathy?

A

Rhodanine stain - highlights copper granules as bright orange-red cytosolic inclusions. Limitation - stain fades over time esp with light exposure (overcome by digitally staining fresh slides).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Copper storage hepatopathy
- Breeds
- Causal gene mutation?
- Pathogenesis

A
  • Bedlington Terriers, Dobers, Labs
  • COMMD1 - homozygous deletion of exon 2 (Bedlington)
  • SNP (all 3 above)

Complete absence/dysfunction of ATP7β (Cu transporter protein responsible for Cu transport into plasma protein ceruloplasmin & Cu bile elimination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe how copper accumulation causes liver injury.

A

Cu exists in an oxidized (cupric [Cu2+]) or reduced (cuprous [Cu1+]) state - so functions as electron acceptor or donor. Allows Cu to participate in redox cycling reactions that promote generation of ROS.
Haber-Weiss/Fenton reaction: generates superoxide (O2−), hydroxyl (OH) radicals & other ROS from H2O2. Effects of ROS: break DNA strands, ER stress & oxidative injury to cell & mitochondrial membranes, impair protein synthesis + promote cell death pathways. Oxidative injury –> consumptive depletion of hepatocytes & mitochondiral antioxidants (glutathione & a-tocopherol) –> perpetuates oxidative injury.
Decreased hepatic & plasma gluthathione & vit E [ ]
Can also exacerbate oxidative injury caused by concurrent extra-hepatic illness (due to glutathione depletion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe histopath findings encountered with copper storage hepatopathy.

A
  1. Accumulation of refractile eosinophilic cytosolic granules in centrilobular (rather than periportal) hepatocytes. Often colocalize with lipofuscin (tan-colored product derived from oxidized membrane lipids).
  2. Copper pigment granulomas - cellular response to dead/dying hepatocytes; populated by macrophages (containing phagocytized hemosiderin, copper, and lipofuscin-laden debris) > fewer lymphocytes, occ Np. Can extend to all zones with progressive disease
  3. Lymphohistiocytic infiltrates
  4. Hepatocyte microvesicular lipid vacuolation - result of mitochondrial & ER injury, seen in severe disease
  5. Mp may sequester iron (phagocytosis of heme-rich cell debris)
  6. Progressive disease - parenchymal remodelling & fibrosis, see regenerative nodules.
  7. Advanced disease - loss of acinar structures & parenchymal distinction. Grossly small pale firm liver with many nodules.
  8. With cirrhosis, Cu accumulates in areas of inflammatory infiltrates or at the margins of regenerative nodules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are indications for initiating copper chelation therapy in dogs?

A

> 1500 mcg/g dry weight regardless of distribution
750 mcg/g dry weight if there is centrilobular accumulation esp in predisposed breeds

Center JAVMA 2021 update: >/=600mcg/g DW if histologic lesions seen with hepatocyte Cu accumulation or if fluctuating ALT activities are seen with no alternative identifiable cause. (as low as 600mcg/g has been associated with copper storage hepatopathy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are 2 rare complications of severe copper storage hepatopathy in dogs?

A
  1. Acute, severe panlobular hepatic necrosis - associated with massive Cu release from damaged hepatocytes –> may cause markedly increased circulating [Cu] & haemolysis. Grossly liver appears normal/plump or has soft pale-yellow necrotic foci.
  2. Acquired Fanconi syndrome (euglycemic glucosuria > acute proximal tubular injury). Can visualise Cu accumulation in PT epithelium of renal biopsies with Rhodanine staining. Clinical recovery possible with intensive supportive care.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Liver copper accumulation in cats - causes & differences with dogs?

A

Cats with slowly progressive cholangitis –> cholestasis –> periportal Cu accumulation.
Vs dogs - pathological hepatic Cu accumulation is centrilobular, cholestasis is an uncommon cause for significant Cu accumulation (even with EHBDO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the key GI bacterial phyla in dogs and cats?

A

Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, Actinobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What RBC abnormalities are more common in dogs with GI lymphoma vs chronic enteropathy?

A

Parachini-Winter JAVMA 2019
Anaemia
3+ RBC anomalies, (Sn 71%, Sp 70%)
Particularly presence of eccentrocytes (29% LSA vs 4% CIE)

Eccentrocytes reflect oxidative injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Differences in oesophagus musculature between dogs & cats? Implications for treatments?

A

Dogs - striated muscle throughout oesophagus
Cats - upper 80% striated, distal 20% smooth muscle
Smooth muscle agents (metoclopramide & cisapride) don’t work to increase oesophageal motility in dogs, but may work to increase distal oesophageal motility in cats.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the 2 types of cricopharyngeal dysphagia?

A
  1. Achalasia = a primary esophageal motility disorder; results from a selective loss of inhibitory myenteric neurons leading to failure of the LES to relax in response to a pharyngeal swallow and impaired esophageal peristalsis.
  2. Assynchrony = lack of coordination between UES relaxation & pharyngeal contraction.

Clinical signs are indistinguishable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Which drugs may be associated with GB mucocoele formation?

A

Thyroxine, trilostane, imidocloprid (esp in Shetland sheepdogs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Nutritional deficiency in …… is of potential concern in dogs with GBM, due to ……

A

Lipid-soluble substances
EHBDO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

DDx for hyperammonemia in dogs/cats?
1 blood test that may help differentiate?

A

Congenital vs acquired PSS, inborn errors of metabolism (IEM; urea cycle enzyme deficiency)
BAST - normal with IEM
Also IEM - young animals. Can measure urine metabolites. Reported in Irish Wolfhounds (hypercitrullinemia). Pekingese, Yorkie; American shorthair, Maine coon.

35
Q

What are the 3 main zymogens in the exocrine pancreas? What 2 mechanisms prevent early activation of pancreatic enzymes & autodigestion?

A

Zymogens - trypsinogen (main one), chymotrypsinogen, procarboxypeptidase
Mechanisms:
- Presence of chyme required –> enterocytes (brush border enzymes) release enteropeptidase –> activates some trypsinogen to trypsin –> newly formed trypsin assists in activating all three zymogens
- Intracellular pancreatic secretory trypsin inhibitor (PTSI) released to inhibit early activation of pancreatic enzymes

36
Q

What are the key players regulate pancreatic enzyme secretion?

A
  1. Presence of fat and protein in the SI lumen (70% secretions) > thought of food (cephalic phase) (20%) > stomach filling (gastric phase 5-10%)
  2. Secretin (from S cells in duodenum & jejunum) = most impt hormone that stimulates pancreatic secretion containing HCO3- (+ H2O) in response to HCl in chyme entering SI from stomach.
  3. Ach (vagal n.) & cholecystokinin (CCK) –> stimulate release of digestive enzymes (+release of bile into SI).
  4. Local enteric NS.
37
Q

In which breed with chronic pancreatitis may immunosuppressive therapy be beneficial?

A

English Cocker Spaniels
Distinct form of CP vs other breeds, similar to autoimmune CP in humans (histo - duct destruction + anti-CD31 lymphocytic infiltrates around venules and ducts)
Other breeds: usually mixed T-cell infiltration & duct hyperplasia on histo.

38
Q

Which bacteria spp can compete with the host for to utilize the B12-IF-receptor complexes in the development of SI dysbiosis?

A

Bacteroides spp. (other bacteria can only complete for free B12)

39
Q

High folate - causes & mechanisms?

A

SI dysbiosis (Bacteroides spp produce folate)
B12 deficiency (folate share common methionine synthesis pathway. B12 def –> traps & accummulates folate –> can decr after B12 supp)

40
Q

Immunoproliferative LP enteritis has been documented in which breed? What are the characteristic clin path & histological features of this disease?

A

Basenjis.
Marked hypoalb + HYPERglob (don’t have alpha heavy chain dz like in humans). Predisposition to LSA.
Histo of intestinal lesions - increased CD4+ & CD8+ T cells.

41
Q

A specific enteropathy in Irish Setters involves sensitivity to what ingredient? What is another breed with similar sensitivity?

A

Gluten.
SCWTs (PLE).

42
Q

What molecular weight of proteins are associated with immunological responses causing GI disease in dogs & cats?

A

20+kDa
Most common types: beef, dairy, fish (for cats)

43
Q

List 5 dog breeds prediposed to EPI? Differences in most common aetiology?

A

Progressive acinar atrophy
-** GSD, Rough coated collies **(autosomal recessive)
- Chow Chow (congenital hypoplasia also reported)
- English Setters (reported in family)

Chronic pancreatitis
- CKCS

44
Q

TLI:
- Cut-off to diagnose EPI (cats vs dogs)?
- Causes for increased TLI?

A

Dogs: <2.5ug/L (with concurrent CSx) highly diagnostic, <1.9ug/L 100% Sp/Sn.
Cats: <8.0ug/L diagnostic
Increased TLI - pancreatitis, renal disease (decr excretion), pancreatic duct obstruction, post-prandium (12-18hr fast)
Interference - hemolysis

45
Q

What 2 other tests can be considered to diagnose EPI in the event of equivocal TLI results? Cut-offs for EPI vs normal?

A
  1. Faecal pancreatic elastase 1 (FPE1)
    - Zymogen produced exclusively within pancreatic acinar cells. Survives intestinal transit unchanged, also unaffected by intestinal inflammation.
    - <10ug/g faeces diagnostic for EPI, >40ug/g = normal exocrine pancreatic function
  2. TLI stimulation test
    - Measure cTLI before & 20mins after stimulation with secretin/CCK IV
    - Lack of stimulation confirms EPI (subclinical EPI - can have low fasting but normal post stim results)
    - In people gold standard: analyse pancreatic secretions after CCK & secretin stimulation, some studies in dogs (but impractical)
  3. Or…just recheck TLI 1 month after
46
Q

Which pancreatic enzyme formulation is recommended (vs not) for EPI tx?

Complications/possible causes for no clinical response to supp?

A
  • Powdered forms recc (commerical vet products available)
  • Enteric-coated pancreatic enzyme tablets NOT recommended (need pancreatic HCO3- to break down coating, deficient in EPI patients, also don’t recc supp)
  • Raw pancreas not recc (BSE, pseudorabies!)

Causes:
- Too low dose
- Inappropriate formulation (enteric coated tabs)
- HypoB12 (not supp)
- Vit K def > coagulopathy (reported)
- Co-morbidities unaddress (IBD, ARE, pancreatitis)
- Dietary (some dogs may need lower fat)

47
Q

Dietary recommendation for EPI?

A

Highly digestible (low fibre), moderate fat (or adjusted based on patient)
Low fat not proven to improve CSx.

48
Q

Normal CBD diameter in dogs vs cats?

A

Dogs: not normally seen on US, <3mm
Cats </= 4mm
(shouldn’t see intrahepatic bile ducts)

49
Q

Liver of dog - most likely ddx? Common concurrent clinical manifestation?

A

Hepatocutaneous syndrome. Honeycomb appearance (hypoechoci nodules with hyperechoic liver parenchyma)
Superficial necrolytic dermatitis - pedal skin lesions

50
Q

What gene mutation is associated with predisposition to pancreatitis in dogs, and what does it encode? Which breeds?

A

SPINK-1 gene (serine protease inhibitor, Kazal type 1).
Encodes pancreatic secretory trypsin inhibitor (PTSI).
PTSI/SPINK-1 binds to trypsin & keeps it in inactive form (trypsinogen) > so prevents early activation of trypsin & autodigestion.
Mini Schnauzers.

(Also can get genetic mutations of trypsinogen (leading to resistance to hydrolysis)

51
Q

Drugs & toxins associated with canine pancreatitis?
What infectious agent is commonly associated with pancreatitis in dogs?

A

Idiosyncratic - azathioprine, L-aspar, clomipramine, meglumine antimionate, phenobarbitone, KBr, combo phenobarb/KBr
True risk factor - sulphonamides
Toxicity (rare) - Zn, lily
Babesia (rossi&raquo_space; gibsoni)

52
Q

Stimuli for zymogen activation > autoactivation of pancreatic enzymes?

A
  • Post-prandial enterokinase release & entry into portal circulation
  • Bile reflux into pancreatic ducts or due to duodenal obstruction
  • Obstruction of pancreatic acinar cells/ducts
  • Thrombin release during bacterial toxemia, ischemia, hypoxia
  • Oxidative stress
  • ROS (produced in proinflammatory response)
  • Hypotension (decreased pancreatic blood flow)
  • Cathepsin B (protease; trypsinogen activator)
  • Acute hyperCa (rare; possible MOA - Ca deposition in the pancreatic duct > Ca activates trypsinogen)
53
Q

Which cells is implicated in the development of pancreatic fibrosis?

A

Pancreatic stellate cells (peri-acinar) - role in regulating ECM production.
CCK & oxidative stress also sensitise acinar cells to injury & necrosis

54
Q

Cats with pancreatitis - what associated condition may develop that is of major concern?
1 biochemical marker that is a negative prognostic indicator?

A

Often associated with SI and/or liver disease.
Hepatic lipidosis.
Vit B12 & vit K deficiencies, hypoK common.

Ionized hypoCa (not in dogs)

55
Q

Based on the ACVIM consensus statement, what are the benefits & recommendations for anti-inflammatory/ immunosuppressive therapy for cats with severe pancreatitis?

A

Cats that are not hyperglycemic:
- AI doses (0.5-1mg/kg PO q24hr tapering), but some recommend IS doses (2mg/kg q12h x5d then 1mg/kg q12h for 6 wks tapering)
Hyperglycemic cats:
- Cyclosporine 5mg/kg PO q24hr for 6 wks. Risks of unmasking latent toxoplasmosis (long term high dose).
Re-evaluate & recheck spec FPL after 2-3 weeks. If improving continue slow taper.

56
Q

When should surgical treatment of EHBDO be considered?

A
  • Acholic faeces (indicates complete biliary obstruction)
  • Failure of icterus to improve >10d (in humans med tx pursued provided resolves within a month)
  • GB rupture
57
Q

Breeds predisposed to chronic hepatitis & lobular dissecting hepatitis? Which breeds tend to have earlier onset of disease?

A

ACVIM consensus
Bedlington Terrier, Dobers, Labs, Dalmatians, Cockers, Eng Springer Spanels, WHWT, Standard Poodles
Cockers & Standard Poodles also for lobular dissecting hepatitis
Dalmatians, Dobers, Eng Springer Spaniels usually younger

58
Q

What molecular biomarker is more sensitive than ALT for dogs with chronic hepatitis?
Which clin path abnormalities are negative prognostic factors?

A

microRNA-122
HyperBIL, increased APTT/PT, hypoalb, not ALT incr.
Ascites (except Cockers), more severe fibrosis
Overall MST 561d, 22d with ascites (likely cirrhosis)

59
Q

What is the potential impact of sampling regenerative nodules & fibrotic regions on interpreting hepatic copper concentrations?

A

Both may underestimate Cu

60
Q

Deficiency in ….. may be associated with chronic hepatitis in affected Cocker Spaniels?

A

alpha-1 anti-trypsin (protease inhibitor) deficiency (accumulation of abnormal A1AT in hepatocytes)

61
Q

List 3 treatment options for copper chelation in dogs with copper storage hepatopathy? MOA & AE?

A

1. D-penicillamine
- Binds Cu in blood to form water-soluble complexes > increased urinary excretion
- Increases metallothionein in hepatocytes (detoxifies intracellular Cu&raquo_space; excreted in urine) & enterocytes (increases faecal elimination).
- Anti-inflam (reduce T cell activity) + anti-fibrotic effects (reduce collagen X-linking)
- AE: GI signs common, proteinuria (glomerulonephritis), skin eruptions (rare)

  1. Zinc
    - Interferes with Cu absorption in the GIT via inducing metallothionein
    - Don’t give with D-pen (latter binds Zn)
    - AE: GI signs common
  2. Dietary copper restriction (prescription diets with <0.12mg/100kcal)

+/- SAME/vit E (for Cu-associated oxidative injury)

62
Q

What renal changes may occur with hepatic copper toxicosis? Do these improve with treatment?

A

Proximal tubular dysfunction > Fanconi-like syndrome. Euglycemic glucosuria, aminoaciduria, granular casts in some dogs.
Yes resolved after copper chelation therapy.

63
Q

How can the measurement of protein C activity be useful in the diagnosis of hepatobiliary disease in dogs?

A

Differentiation of congenital PSS from PHPV/MVD
Protein C activity >70% in MVD (marked MVD can have borderline levels)
<70% in cPSS, increased to >70% after successful shunt attenuation

64
Q

What coagulation abnormalities on TEG are common in dogs with:
1) Congenial PSS
2) Chronic hepatitis
3) Acute liver failure
4) Biliary disease (GBM)?

A

CPSS - hypercoagulable (decreased protein C & AT; incr vWF & FVIII). High fibrinogen with high G on TEG > more likely to develop HE (pro-inflammatory state > thrombosis)

CH - hyperfibrinolytic & hypocoagulable with cirrhosis (decr platelets, incr PT/PTT, decr fibrinogen)

Acute liver failure - hyperfibrinolytic (decr protein C & AT, incr APTT, decr platelets)

Biliary dz/GBM: hypercoagulable

65
Q

Contraindications for liver biopsies?

A
  • PT/APTT > 1.5x URI
  • Platelets <50-80K
  • BMBT >4mins (dogs), >3.3mins (cats)
  • Anemic PCV <30%
  • Fibrinogen <100mg/dL (<50% lower RI)
  • vWF activity <50%
  • Ascites (relative contraindication; purported incr bleeding risk & more challenging to do lap bx)
  • Infectious dz (may spread by bx)
  • Presumed HSA (go for excisional bx)
  • Other co-morbidites making patient unstable for GA
66
Q

What is the main stimulus for hepatic fibrosis formation?

A

Transforming growth factor-b = most potent fibrogenic inflammatory cytokine, pdtn by Kupffer cells. (other cytokines e.g. PDGF)
Activation of hepatic stellate cells > express smooth muscle-specific a-actin & secrete high-density matrix and collagen into the space of Disse.

67
Q

Scottish Terriers with vacuolar hepatopathy are at increased risk of acquiring what disease? What is the pathogenesis behind vacuolar hepatopathy?

A

Hepatocellular carcinoma.
50% dogs have signs of HAC, but variable adrenal function test results (increased progesterone & androstenedione post ACTH stim).

68
Q

What are reported causes of destructive cholangitis in dogs? What similar clinical sign does it share with bile duct obstruction?

A

Idiosyncratic reaction to TMPS, canine distemper, some hepatotoxins.
Causes v severe intra-hepatic cholestasis & icterus –> acholic faeces.
Histo - biliary epithelium necrosis

69
Q

What external factors may influence dysbiosis index results?

A
  • Omeprazole/PPI tx (should stop 1-2 weeks before assessing DI)
  • Abx (metronidazole, tylosin) - should stop 3-4 weeks before assessing DI, effect may be mths
  • Home-made diets (BARF) especially those with high protein and fat but low fiber content - increases DI but should have normal abundance of C. hiranonis.
70
Q

DDx for acquired megaO

A

Immune-mediated dz
- MG (25-30% megaO dogs)
- SLE, inflammatory – polymyositis, polymyopathies, dermatomyositis (collies, shelties)
Neuro
- Polyneuropathies
- Brainstem disease
- Dysautonomia (dilated colon, dry nose, KCs, bradycardia that responds poorly to atropine); degenerative lesions involving autonomic ganglia
Glycogen storage disease (type II)
Idiopathic
Infectious – botulism, distemper
Neoplasia, thymoma
Toxicities – lead & thallium toxicity
Endocrine – Addison’s, hypothyroidism, pituitary dwarfism

71
Q

Which 2 GI conditions frequently noted in brachycephalic dogs warrant surgical correction?

A

Permanent hiatal hernia
Pyloric stenosis

72
Q

What GI lesions (endoscopic or imaging) are observed particularly with brachycephalic dogs?

What % of brachycephalic dogs exhibit improvement in GI signs following BOAS surgery?

A

Redundant esophagus (deviation) - can be marked (similar to PRAA associated)
Oesophagitis
GERD
Sliding HH (type 1)
Delayed gastric emptying
Gastritis (lymphofollicular) - punctate lesions on endscopic
Pyloric mucosal folds hypertrophy
Pyloric stenosis
Duodenitis (dilated lacteals) w/o signs of PLE - NB: pugs have severe form of PLE

88%

73
Q

What infectious disease has been associated with development of oesophageal neoplasia in dogs?

A

Spirocerca lupi - malignant tranformation of oesophageal granulomas > sarcoma

74
Q

Name the gastric mucosal cell types involved in gastric acid secretion and their roles.

A
  1. Mucous/neck cells: produce mucus and gastric lipase
  2. Chief cells: secrete pepsinogen & leptin
  3. Parietal cells: produce HCl & intrinsic factor
  4. Enterochromaffin-like cells: produce histamine
  5. D cells: provduce somatostatin & amylin
  6. Enterochromaffin cells: secrete ANP, serotonin, adrenomedullin
  7. A-like or Gr cells: secrete ghrelin & obestatin
75
Q

Major gastric acid secretagogues?

A

Gastrin
ACh
Histamine (most potent one)

76
Q

Polymorphisms in …. have been associated with disease susceptibility to IBD in dogs

A

TLR-4 & TLR-5

77
Q

What

List some treatment considerations for dogs with perianal fistulas (including novel options from recent literature).

A
  1. Immunomodulatory tx
    - Cyclosporine A, topical tacrolimus: bind to cyclophilin-1 (intracellular protein) > inhibits calcineurin  decreases IL-2 production > decreases proliferation/activation of Th & Tc lymphocytes. Study - reduces lesional IL-2 expression post-tx.
    - Pred @ AI doses
    - Azathioprine?
  2. +/- abx (metronidazole for immunomodulatory tx)
  3. Intra-lesional mesenchymal SCs - small study, may be promising for dogs with refractory dz. Immunomodulatory.
  4. Hypoallergenic/novel protein diets (50% dogs have colitis, AFR possible role in PAF pathogenesis)
  5. Sx - not really recc.
  6. Supportive - stool softeners, pain relief
78
Q

Which gene mutations have been associated with perianal fistulas in dogs? Which breed?

A

GSDs.
ADAMTS16 & CTNND2 gene regions on chromosome 34

79
Q

Serum gastrin ….. above RI is supportive of gastrinoma. Elevations can also occur from what causes?

A

3x
CKD, liver disease, antacids/PPIs

80
Q

What treatment options are available for feline chronic gingivostomatitis and what is the reported response rates?

A

Mesenchymal SCs: immunomodulatory, inhibit T cell proliferation. 71% positive response. Normalise CD4/CD8 ratio in FCGS cats.
Recombinant feline interferon omega: similar efficacy to short-term pred.
Pred - 23% sig improvement of which 7% clinical remission
Dental extractions - partial 1st then full mouth if no improvement. 28% CR, 39% substantial clinical improvement, 26% little improvement, 6% none.

81
Q

Name 3 paraneoplastic syndromes that may be observed with GI smooth muscle tumors or GIST?

A
  1. Hypoglycaemia (production of insulin-like growth factor II-like peptide)
  2. Erythrocytosis (pdtn of EPO-like molecule)
  3. 2’ nephrogenic DI
82
Q

What signalment is overrepresented in feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF)? Where are lesions typically located?
What diagnostic tests should be considered and what treatments have been recommended?

A

Middle aged (7yo), Ragdolls, males.
Pylorus or ICJ. Makred enlargement of LNs at root of mesentery (ddx lymphoblastic LSA)
Hard/’gritty’ masses due to internal mature collagen bundles.
Dx: bacterial detection within masses using culture or conventional LM, special stains (Trichome to highlight collagen, others to r/o infx), FISH.
Tx sx (debulking/complete resection), immunosuppressive tx, abx (amoxy clav)

83
Q

Cisapride
- MOA (which receptors & where)

A

5-HT4-receptor agonist > stimulates Ach release at GI s.m. myenteric plexus
5-HT1- & 5-HT3-receptor antagonist of enteric cholinergic neurons
Direct 5-HT2-alpha receptor agonist on colonic s.m.